Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Moore
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Physiology
Genes & Molecular Sequences
Anatomy
Sign-in to see full Profile
Network (preview)
11
Larsen, Reed
11
Lee, Yoon-Kwang
10
Zhang, Jun
9
Seol, W
8
Qatanani, Mohammed
8
Huang, Wendong
8
Harney, John
6
Koenig, Ronald
6
Tzameli, Iphigenia
6
Wei, Ping
4
Zavacki, Ann Marie
4
Urizar, Nancy
4
Kelly, Daniel
4
Kim, Han-Jong
4
Han, Yunqing
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Moore (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Dong Bingning; Saha Pradip K; Huang Wendong; Chen Wenling; Abu-Elheiga Lutfi A; Wakil Salih J; Stevens Robert D; Ilkayeva Olga; Newgard Christopher B; Chan Lawrence; Moore David D
Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18831-6.
-
2009: Dong Bingning; Qatanani Mohammed; Moore David D
Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes.
Hepatology (Baltimore, Md.) 2009;50(2):622-9.
-
2009: McKenna Neil J; Cooney Austin J; DeMayo Francesco J; Downes Michael; Glass Christopher K; Lanz Rainer B; Lazar Mitchell A; Mangelsdorf David J; Moore David D; Qin Jun; Steffen David L; Tsai Ming-Jer; Tsai Sophia Y; Yu Ruth; Margolis Ronald N; Evans Ronald M; O'Malley Bert W
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.
Molecular endocrinology (Baltimore, Md.) 2009;23(6):740-6.
-
2009: Zhang Lisheng; Huang Xiongfei; Meng Zhipeng; Dong Bingning; Shiah Steven; Moore David D; Huang Wendong
Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.
Molecular endocrinology (Baltimore, Md.) 2009;23(2):137-45.
-
2009: Ma Ke; Xiao Rui; Tseng Hsiu-Ting; Shan Lu; Fu Loning; Moore David D
Circadian dysregulation disrupts bile Acid homeostasis.
PloS one 2009;4(8):e6843.
-
2008: Wang Yan-Dong; Chen Wei-Dong; Moore David D; Huang Wendong
FXR: a metabolic regulator and cell protector.
Cell research 2008;18(11):1087-95.
-
2008: Park Young Joo; Qatanani Mohammed; Chua Steven S; LaRey Jennifer L; Johnson Stacy A; Watanabe Mitsuhiro; Moore David D; Lee Yoon Kwang
Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Hepatology (Baltimore, Md.) 2008;47(5):1578-86.
-
2008: Lee Yoon-Kwang; Moore David D
Liver receptor homolog-1, an emerging metabolic modulator.
Frontiers in bioscience : a journal and virtual library 2008;13():5950-8.
-
2007: Carter Beth A; Taylor Olga A; Prendergast Daniel R; Zimmerman Tracy L; Von Furstenberg Richard; Moore David D; Karpen Saul J
Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.
Pediatric research 2007;62(3):301-6.
-
2007: Ricketts Marie-Louise; Boekschoten Mark V; Kreeft Arja J; Hooiveld Guido J E J; Moen Corina J A; Müller Michael; Frants Rune R; Kasanmoentalib Soemini; Post Sabine M; Princen Hans M G; Porter J Gordon; Katan Martijn B; Hofker Marten H; Moore David D
The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Molecular endocrinology (Baltimore, Md.) 2007;21(7):1603-16.
-
2007: Moore David D
Physiology. Sister act.
Science (New York, N.Y.) 2007;316(5830):1436-8.
-
2007: Yang Fan; Huang Xiongfei; Yi Tangsheng; Yen Yun; Moore David D; Huang Wendong
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
Cancer research 2007;67(3):863-7.
-
2006: Moore David D; Kato Shigeaki; Xie Wen; Mangelsdorf David J; Schmidt Daniel R; Xiao Rui; Kliewer Steven A
International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor.
Pharmacological reviews 2006;58(4):742-59.
-
2006: Huang Wendong; Ma Ke; Zhang Jun; Qatanani Mohammed; Cuvillier James; Liu Jun; Dong Bingning; Huang Xiongfei; Moore David D
Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.
Science (New York, N.Y.) 2006;312(5771):233-6.
-
2006: Ma Ke; Saha Pradip K; Chan Lawrence; Moore David D
Farnesoid X receptor is essential for normal glucose homeostasis.
The Journal of clinical investigation 2006;116(4):1102-9.
-
2006: Lee Yoon-Kwang; Choi Yun-Hee; Chua Steven; Park Young Joo; Moore David D
Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation.
The Journal of biological chemistry 2006;281(12):7850-5.
-
2005: Qatanani M; Moore D D
CAR, the continuously advancing receptor, in drug metabolism and disease.
Current drug metabolism 2005;6(4):329-39.
-
2005: Ricketts Marie-Louise; Moore David D; Banz William J; Mezei Orsolya; Shay Neil F
Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review.
The Journal of nutritional biochemistry 2005;16(6):321-30.
-
2005: Huang Wendong; Zhang Jun; Washington Michele; Liu Jun; Parant John M; Lozano Guillermina; Moore David D
Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.
Molecular endocrinology (Baltimore, Md.) 2005;19(6):1646-53.
-
2005: Qatanani Mohammed; Zhang Jun; Moore David D
Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism.
Endocrinology 2005;146(3):995-1002.
-
2005: Moore David D
'No, really, how do they work?'.
Genes & development 2005;19(4):413-4.
-
2005: Moore David D
CAR: three new models for a problem child.
Cell metabolism 2005;1(1):6-8.
-
2004: Zhang Jun; Huang Wendong; Qatanani Mohammed; Evans Ronald M; Moore David D
The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity.
The Journal of biological chemistry 2004;279(47):49517-22.
-
2004: Huang Wendong; Zhang Jun; Wei Ping; Schrader William T; Moore David D
Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR.
Molecular endocrinology (Baltimore, Md.) 2004;18(10):2402-8.
-
2004: Qatanani Mohammed; Wei Ping; Moore David D
Alterations in the distribution and orexigenic effects of dexamethasone in CAR-null mice.
Pharmacology, biochemistry, and behavior 2004;78(2):285-91.
-
2004: Huang Wendong; Zhang Jun; Moore David D
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR.
The Journal of clinical investigation 2004;113(1):137-43.
-
2003: Wang Li; Han Yunqing; Kim Chang-Soo; Lee Yoon-Kwang; Moore David D
Resistance of SHP-null mice to bile acid-induced liver damage.
The Journal of biological chemistry 2003;278(45):44475-81.
-
2003: Huang Wendong; Zhang Jun; Chua Steven S; Qatanani Mohammed; Han Yunqing; Granata Riccarda; Moore David D
Induction of bilirubin clearance by the constitutive androstane receptor (CAR).
Proceedings of the National Academy of Sciences of the United States of America 2003;100(7):4156-61.
-
2003: Lee Yoon-Kwang; Moore David D
The orphan receptor SHP and the three-hybrid interference assay.
Methods in enzymology 2003;364():152-9.
-
2003: Urizar Nancy L; Moore David D
GUGULIPID: a natural cholesterol-lowering agent.
Annual review of nutrition 2003;23():303-13.
-
2002: Moore David D
Does loss of bile acid homeostasis make mice melancholy?
The Journal of clinical investigation 2002;110(8):1067-9.
-
2002: Zhang Jun; Huang Wendong; Chua Steven S; Wei Ping; Moore David D
Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.
Science (New York, N.Y.) 2002;298(5592):422-4.
-
2002: Chen Qin; Dowhan Dennis H; Liang Dongcai; Moore David D; Overbeek Paul A
CREB-binding protein/p300 co-activation of crystallin gene expression.
The Journal of biological chemistry 2002;277(27):24081-9.
-
2002: Wang Li; Lee Yoon-Kwang; Bundman Donnie; Han Yunqing; Thevananther Sundararajah; Kim Chang Soo; Chua Steven S; Wei Ping; Heyman Richard A; Karin Michael; Moore David D
Redundant pathways for negative feedback regulation of bile acid production.
Developmental cell 2002;2(6):721-31.
-
2002: Urizar Nancy L; Liverman Amy B; Dodds D'Nette T; Silva Frank Valentin; Ordentlich Peter; Yan Yingzhuo; Gonzalez Frank J; Heyman Richard A; Mangelsdorf David J; Moore David D
A natural product that lowers cholesterol as an antagonist ligand for FXR.
Science (New York, N.Y.) 2002;296(5573):1703-6.
-
2002: Hwang Sandy T; Urizar Nancy L; Moore David D; Henning Susan J
Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor.
Gastroenterology 2002;122(5):1483-92.
-
2002: Seo Young-Woo; Sanyal Sabyasachi; Kim Han-Jong; Won Dong Hwan; An Jee-Young; Amano Tosikazu; Zavacki Ann Marie; Kwon Hyuk-Bang; Shi Yun-Bo; Kim Won-Sun; Kang Heonjoong; Moore David D; Choi Hueng-Sik
FOR, a novel orphan nuclear receptor related to farnesoid X receptor.
The Journal of biological chemistry 2002;277(20):17836-44.
-
2002: Sanyal Sabyasachi; Kim Joon-Young; Kim Han-Jong; Takeda Jun; Lee Yoon-Kwang; Moore David D; Choi Hueng-Sik
Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms.
The Journal of biological chemistry 2002;277(3):1739-48.
-
2002: Lee Yoon-Kwang; Moore David D
Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.
The Journal of biological chemistry 2002;277(4):2463-7.
-
2002: Wei P; Zhang J; Dowhan D H; Han Y; Moore D D
Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response.
The pharmacogenomics journal 2002;2(2):117-26.
-
2001: Pissios P; Tzameli I; Moore D D
New insights into receptor ligand binding domains from a novel assembly assay.
The Journal of steroid biochemistry and molecular biology 2001;76(1-5):3-7.
-
2001: Tzameli I; Moore D D
Role reversal: new insights from new ligands for the xenobiotic receptor CAR.
Trends in endocrinology and metabolism: TEM 2001;12(1):7-10.
-
2000: Urizar N L; Dowhan D H; Moore D D
The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
The Journal of biological chemistry 2000;275(50):39313-7.
-
2000: Wei P; Zhang J; Egan-Hafley M; Liang S; Moore D D
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.
Nature 2000;407(6806):920-3.
-
2000: Pissios P; Tzameli I; Kushner P; Moore D D
Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
Molecular cell 2000;6(2):245-53.
-
2000: Tzameli I; Pissios P; Schuetz E G; Moore D D
The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR.
Molecular and cellular biology 2000;20(9):2951-8.
-
2000: Laffitte B A; Kast H R; Nguyen C M; Zavacki A M; Moore D D; Edwards P A
Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.
The Journal of biological chemistry 2000;275(14):10638-47.
-
2000: Lee Y K; Dell H; Dowhan D H; Hadzopoulou-Cladaras M; Moore D D
The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.
Molecular and cellular biology 2000;20(1):187-95.
-
1999: Kim H J; Yi J Y; Sung H S; Moore D D; Jhun B H; Lee Y C; Lee J W
Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation.
Molecular and cellular biology 1999;19(9):6323-32.
-
1999: Lee Y K; Parker K L; Choi H S; Moore D D
Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers.
The Journal of biological chemistry 1999;274(30):20869-73.
-
1999: Parks D J; Blanchard S G; Bledsoe R K; Chandra G; Consler T G; Kliewer S A; Stimmel J B; Willson T M; Zavacki A M; Moore D D; Lehmann J M
Bile acids: natural ligands for an orphan nuclear receptor.
Science (New York, N.Y.) 1999;284(5418):1365-8.
-
1999: Koh Y S; Moore D D
Linkage of the nuclear hormone receptor genes NR1D2, THRB, and RARB: evidence for an ancient, large-scale duplication.
Genomics 1999;57(2):289-92.
-
1998: Forman B M; Tzameli I; Choi H S; Chen J; Simha D; Seol W; Evans R M; Moore D D
Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta.
Nature 1998;395(6702):612-5.
-
1998: Seol W; Hanstein B; Brown M; Moore D D
Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).
Molecular endocrinology (Baltimore, Md.) 1998;12(10):1551-7.
-
1998: Lee H K; Lee Y K; Park S H; Kim Y S; Park S H; Lee J W; Kwon H B; Soh J; Moore D D; Choi H S
Structure and expression of the orphan nuclear receptor SHP gene.
The Journal of biological chemistry 1998;273(23):14398-402.
-
1998: Na S Y; Kim H J; Lee S K; Choi H S; Na D S; Lee M O; Chung M; Moore D D; Lee J W
IkappaBbeta interacts with the retinoid X receptor and inhibits retinoid-dependent transactivation in lipopolysaccharide-treated cells.
The Journal of biological chemistry 1998;273(6):3212-5.
-
1997: Seol W; Chung M; Moore D D
Novel receptor interaction and repression domains in the orphan receptor SHP.
Molecular and cellular biology 1997;17(12):7126-31.
-
1997: Choi H S; Chung M; Tzameli I; Simha D; Lee Y K; Seol W; Moore D D
Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR.
The Journal of biological chemistry 1997;272(38):23565-71.
-
1997: Zavacki A M; Lehmann J M; Seol W; Willson T M; Kliewer S A; Moore D D
Activation of the orphan receptor RIP14 by retinoids.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7909-14.
-
1996: Seol W; Mahon M J; Lee Y K; Moore D D
Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
Molecular endocrinology (Baltimore, Md.) 1996;10(12):1646-55.
-
1996: Seol W; Choi H S; Moore D D
An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors.
Science (New York, N.Y.) 1996;272(5266):1336-9.
-
1996: Choi H S; Seol W; Moore D D
A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily.
The Journal of steroid biochemistry and molecular biology 1996;56(1-6 Spec No):23-30.
-
1995: Dunn M K; Mercola M; Moore D D
Cyclopamine, a steroidal alkaloid, disrupts development of cranial neural crest cells in Xenopus.
Developmental dynamics : an official publication of the American Association of Anatomists 1995;202(3):255-70.
-
1995: Lee J W; Choi H S; Gyuris J; Brent R; Moore D D
Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.
Molecular endocrinology (Baltimore, Md.) 1995;9(2):243-54.
-
1995: Seol W; Choi H S; Moore D D
Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.
Molecular endocrinology (Baltimore, Md.) 1995;9(1):72-85.
-
1994: Gulick T; Cresci S; Caira T; Moore D D; Kelly D P
The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(23):11012-6.
-
1994: Castelein H; Gulick T; Declercq P E; Mannaerts G P; Moore D D; Baes M I
The peroxisome proliferator activated receptor regulates malic enzyme gene expression.
The Journal of biological chemistry 1994;269(43):26754-8.
-
1994: Dumas B; Harding H P; Choi H S; Lehmann K A; Chung M; Lazar M A; Moore D D
A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb.
Molecular endocrinology (Baltimore, Md.) 1994;8(8):996-1005.
-
1994: Carter M E; Gulick T; Moore D D; Kelly D P
A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs.
Molecular and cellular biology 1994;14(7):4360-72.
-
1994: Baes M; Gulick T; Choi H S; Martinoli M G; Simha D; Moore D D
A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements.
Molecular and cellular biology 1994;14(3):1544-52.
-
1993: Choi H S; Moore D D
Induction of c-fos and c-jun gene expression by phenolic antioxidants.
Molecular endocrinology (Baltimore, Md.) 1993;7(12):1596-602.
-
1993: Carter M E; Gulick T; Raisher B D; Caira T; Ladias J A; Moore D D; Kelly D P
Hepatocyte nuclear factor-4 activates medium chain acyl-CoA dehydrogenase gene transcription by interacting with a complex regulatory element.
The Journal of biological chemistry 1993;268(19):13805-10.
-
1992: Lee J W; Gulick T; Moore D D
Thyroid hormone receptor dimerization function maps to a conserved subregion of the ligand binding domain.
Molecular endocrinology (Baltimore, Md.) 1992;6(11):1867-73.
-
1992: Georgopoulos K; Moore D D; Derfler B
Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment.
Science (New York, N.Y.) 1992;258(5083):808-12.
-
1992: Williams G R; Harney J W; Moore D D; Larsen P R; Brent G A
Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors.
Molecular endocrinology (Baltimore, Md.) 1992;6(10):1527-37.
-
1992: Raisher B D; Gulick T; Zhang Z; Strauss A W; Moore D D; Kelly D P
Identification of a novel retinoid-responsive element in the promoter region of the medium chain acyl-coenzyme A dehydrogenase gene.
The Journal of biological chemistry 1992;267(28):20264-9.
-
1992: Brent G A; Williams G R; Harney J W; Forman B M; Samuels H H; Moore D D; Larsen P R
Capacity for cooperative binding of thyroid hormone (T3) receptor dimers defines wild type T3 response elements.
Molecular endocrinology (Baltimore, Md.) 1992;6(4):502-14.
-
1992: Konzak K E; Moore D D
Functional isoforms of Pit-1 generated by alternative messenger RNA splicing.
Molecular endocrinology (Baltimore, Md.) 1992;6(2):241-7.
-
1992: Georgopoulos K; Morgan B A; Moore D D
Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer.
Molecular and cellular biology 1992;12(2):747-57.
-
1991: Moore D D; Brent G A
Thyroid hormone: half-sites and insights. Molecular Approaches to the Study of Thyroid hormone Action: a Keystone Symposium, Tamarron, CO, USA, March 8-14, 1991.
The New biologist 1991;3(9):835-44.
-
1991: Brent G A; Williams G R; Harney J W; Forman B M; Samuels H H; Moore D D; Larsen P R
Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,3'-triiodothyronine.
Molecular endocrinology (Baltimore, Md.) 1991;5(4):542-8.
-
1990: Koenig R J; Brent G A; Larsen P R; Moore D D
Direct repeats.
Nature 1990;345(6276):584.
-
1990: Moore D D
Diversity and unity in the nuclear hormone receptors: a terpenoid receptor superfamily.
The New biologist 1990;2(1):100-5.
-
1989: Brent G A; Harney J W; Chen Y; Warne R L; Moore D D; Larsen P R
Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element.
Molecular endocrinology (Baltimore, Md.) 1989;3(12):1996-2004.
-
1989: Brent G A; Dunn M K; Harney J W; Gulick T; Larsen P R; Moore D D
Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor.
The New biologist 1989;1(3):329-36.
-
1989: Selden R F; Yun J S; Moore D D; Rowe M E; Malia M A; Wagner T E; Goodman H M
Glucocorticoid regulation of human growth hormone expression in transgenic mice and transiently transfected cells.
The Journal of endocrinology 1989;122(1):49-60.
-
1989: Hodin R A; Lazar M A; Wintman B I; Darling D S; Koenig R J; Larsen P R; Moore D D; Chin W W
Identification of a thyroid hormone receptor that is pituitary-specific.
Science (New York, N.Y.) 1989;244(4900):76-9.
-
1989: Koenig R J; Lazar M A; Hodin R A; Brent G A; Larsen P R; Chin W W; Moore D D
Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing.
Nature 1989;337(6208):659-61.
-
1989: Brent G A; Larsen P R; Harney J W; Koenig R J; Moore D D
Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected beta type thyroid hormone receptor.
The Journal of biological chemistry 1989;264(1):178-82.
-
1988: Guérin S L; Moore D D
DNAse I footprint analysis of nuclear proteins from pituitary and nonpituitary cells that specifically bind to the rat growth hormone promoter and 5'-regulatory region.
Molecular endocrinology (Baltimore, Md.) 1988;2(11):1101-7.
-
1988: Brent G A; Harney J W; Moore D D; Larsen P R
Multihormonal regulation of the human, rat, and bovine growth hormone promoters: differential effects of 3',5'-cyclic adenosine monophosphate, thyroid hormone, and glucocorticoids.
Molecular endocrinology (Baltimore, Md.) 1988;2(9):792-8.
-
1988: Tripputi P; Guérin S L; Moore D D
Two mechanisms for the extinction of gene expression in hybrid cells.
Science (New York, N.Y.) 1988;241(4870):1205-7.
-
1988: Bunker C A; Moore D D
Secretion of Escherichia coli chloramphenicol acetyltransferase by mammalian cells.
Gene 1988;67(2):279-86.
-
1988: Koenig R J; Warne R L; Brent G A; Harney J W; Larsen P R; Moore D D
Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(14):5031-5.
-
1987: Koenig R J; Brent G A; Warne R L; Larsen P R; Moore D D
Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormone.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(16):5670-4.
-
1986: Selden R F; Howie K B; Rowe M E; Goodman H M; Moore D D
Human growth hormone as a reporter gene in regulation studies employing transient gene expression.
Molecular and cellular biology 1986;6(9):3173-9.
Sign-in to see more